Clinical Trial Update: The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oral omeprazole and IV pantoprazole for hypersecretion of gastric acid in patients with gastrinoma and Zollinger-Ellison syndrome; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrinoma
• Zollinger-ellison Syndrome

Drugs mentioned

• Omeprazole (Omeprazole)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Gastrinoma, Zollinger Ellison Syndrome | Phase 2 | Status: COMPLETED